Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation

被引：6

作者：

Sekhri, Arunabh ^{[1
]}

Liu, Delong ^{[1
]}

Rasu, Muhammad ^{[1
]}

Ahmed, Nasir ^{[1
]}

Ahmed, Tauseef ^{[1
]}

Seiter, Karen ^{[1
]}

机构：

[1] New York Med Coll, Dept Med, Valhalla, NY 10595 USA

来源：

LEUKEMIA RESEARCH | 2009年 / 33卷 / 09期

关键词：

Chronic myelogenous leukemia; Allogeneic transplantation; Long term follow-up; STEM-CELL TRANSPLANTATION; CHRONIC MYELOID-LEUKEMIA; IMATINIB; INFUSIONS; SURVIVAL; THERAPY;

D O I：

10.1016/j.leukres.2009.03.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow transplantation, respectively. These patients emphasize the need for long term follow-up of such patients. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：1291 / 1293

页数：3

共 8 条

[1] Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation [J].

Collins, RH ;

Shpilberg, O ;

Drobyski, WR ;

Porter, DL ;

Giralt, S ;

Champlin, R ;

Goodman, SA ;

Wolff, SN ;

Hu, W ;

Verfaillie, C ;

List, A ;

Dalton, W ;

Ognoskie, N ;

Chetrit, A ;

Antin, JH ;

Nemunaitis, J .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :433-444

[2] Health and functional status of long-term survivors of bone marrow transplantation [J].

Duell, T ;

vanLint, MT ;

Ljungman, P ;

Tichelli, A ;

Socie, G ;

Apperley, JF ;

Weiss, M ;

Cohen, A ;

Nekolla, E ;

Kolb, HJ .

ANNALS OF INTERNAL MEDICINE, 1997, 126 (03) :184-+

[3]

Gale RP, 1998, BLOOD, V91, P1810

[4] Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia [J].

Giralt, Sergio A. ;

Arora, Mukta ;

Goldman, John M. ;

Lee, Stephanie J. ;

Maziarz, Richard T. ;

McCarthy, Philip L. ;

Sobocinski, Kathleen A. ;

Horowitz, Mary M. .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (05) :461-467

[5] Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia [J].

Kantarjian, HM ;

O'Brien, S ;

Cortes, JE ;

Giralt, SA ;

Rios, MB ;

Shan, JQ ;

Giles, FJ ;

Thomas, DA ;

Faderl, S ;

De Lima, M ;

Garcia-Manero, G ;

Champlin, R ;

Arlinghaus, R ;

Talpaz, M .

BLOOD, 2002, 100 (05) :1590-1595

[6] Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia [J].

Olavarria, E ;

Ottmann, OG ;

Deininger, M ;

Clark, RE ;

Bandini, G ;

Byrne, J ;

Lipton, J ;

Vitek, A ;

Michallet, M ;

Siegert, W ;

Ullmann, A ;

Wassmann, B ;

Niederwieser, D ;

Fischer, T .

LEUKEMIA, 2003, 17 (09) :1707-1712

[7] Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions [J].

Raiola, AM ;

Van Lint, MT ;

Valbonesi, M ;

Lamparelli, T ;

Gualandi, F ;

Occhini, D ;

Bregante, S ;

di Grazia, C ;

Dominietto, A ;

Soracco, M ;

Romagnani, C ;

Vassallo, F ;

Casini, M ;

Bruno, B ;

Frassoni, F ;

Bacigalupo, A .

BONE MARROW TRANSPLANTATION, 2003, 31 (08) :687-693

[8] Long-term survival and late deaths after allogeneic bone marrow transplantation [J].

Socié, G ;

Stone, JV ;

Wingard, JR ;

Weisdorf, D ;

Henslee-Downey, PJ ;

Bredeson, C ;

Cahn, JY ;

Passweg, JR ;

Rowlings, PA ;

Schouten, HC ;

Kolb, HJ ;

Klein, JP .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (01) :14-21

← 1 →